Table 1.
Clinical manifestations of the SLE patients studied (N=289)
| Clinical manifestations (cumulative since SLE diagnosis) |
Number (%) |
|---|---|
| Arthritis | 205 (71) |
|
| |
| Myositis | 4 (1) |
|
| |
| Facial rash | 140 (48) |
|
| |
| Raynaud’s phenomenon | 51 (18) |
|
| |
| Discoid lupus | 25 (9) |
|
| |
| Mucosal ulceration | 45 (16) |
|
| |
| Photosensitivity | 82 (28) |
|
| |
| Alopecia | 87 (30) |
|
| |
| Hemolytic anemia | 53 (18) |
|
| |
| Leukopenia (<4 × 109/L) | 115 (40) |
|
| |
| Thrombocytopenia (<100 × 109/L) | 74 (26) |
|
| |
| Lymphopenia (<1.5 × 109/L) | 206 (71) |
|
| |
| Lymphadenopathy | 46 (16) |
|
| |
| Seizure | 15 (5) |
|
| |
| Psychosis | 11 (4) |
|
| |
| Myelopathy | 4 (1) |
|
| |
| Acute confusional state | 3 (1) |
|
| |
| Neuropathy (peripheral or cranial) | 5 (2) |
|
| |
| Optic neuritis | 2 (1) |
|
| |
| Renal | 169 (58) |
|
| |
| Serositis | 40 (14) |
|
| |
| Autoantibodies | |
| Anti-dsDNA | 218 (75) |
| Anti-Sm | 44 (15) |
| Anti-Ro | 162 (56) |
| Anti-La | 49 (17) |
| Anti-nRNP | 82 (28) |
| Anti-aCL-IgG | 93 (32) |
| LAC | 57 (20) |
SLE = systemic lupus erythematosus; aCL = anti-cardiolipin; LAC = lupus anticoagulant